QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors
- PMID: 21040493
- DOI: 10.1111/j.1747-0285.2010.01030.x
QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors
Abstract
Quantitative structure-activity relationship studies on 54 aminothiazole derivatives as Aurora A kinase inhibitors were performed to explore the important factors affecting their biologic activity. For 2D-quantitative structure-activity relationship study, genetic algorithm combined with multiple linear regression was used to select significant molecular descriptors. The MLR model gave squared correlation coefficient of 0.828 and squared cross-validated correlation coefficient of 0.771 for the training set compounds. Comparative molecular field analysis and comparative molecular similarity indices analysis were used to develop 3D-quantitative structure-activity relationship models. The comparative molecular field analysis model gave cross-validated correlation coefficient q² of 0.695 and non-cross-validated correlation coefficient r² of 0.977. For comparative molecular similarity indices analysis model, the corresponding q² and r² were 0.698 and 0.960, respectively. The proposed 3D-quantitative structure-activity relationship models were validated by the test set compounds not used in the modeling process, with r²(pred) values of 0.788 for comparative molecular field analysis and 0.798 for comparative molecular similarity indices analysis. The 3D contour maps suggested that further modification of the aniline group of compound 22 considering electrostatic, hydrophobic and hydrogen bond properties would influence the inhibitory activity. The results from quantitative structure-activity relationship models would be very useful to understand the structure-activity relationship of these inhibitors and to guide the further structural modification of new potential inhibitors.
© 2010 John Wiley & Sons A/S.
Similar articles
-
Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.Chem Biol Drug Des. 2010 Sep 1;76(3):245-54. doi: 10.1111/j.1747-0285.2010.01006.x. Epub 2010 Jul 5. Chem Biol Drug Des. 2010. PMID: 20626407
-
Structural requirements of isoquinolones as novel selective c-Jun N-terminal kinase 1 inhibitors: 2D and 3D QSAR analyses.Chem Biol Drug Des. 2011 Apr;77(4):248-54. doi: 10.1111/j.1747-0285.2010.01068.x. Epub 2011 Jan 28. Chem Biol Drug Des. 2011. PMID: 21276204
-
Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.Eur J Med Chem. 2011 Jan;46(1):77-94. doi: 10.1016/j.ejmech.2010.10.017. Epub 2010 Oct 26. Eur J Med Chem. 2011. PMID: 21093113
-
Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.Eur J Med Chem. 2008 Apr;43(4):830-8. doi: 10.1016/j.ejmech.2007.06.009. Epub 2007 Jul 6. Eur J Med Chem. 2008. PMID: 17706839
-
3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation.Eur J Med Chem. 2009 Jul;44(7):2888-95. doi: 10.1016/j.ejmech.2008.12.006. Epub 2008 Dec 16. Eur J Med Chem. 2009. PMID: 19128859
Cited by
-
An Overview on Synthetic 2-Aminothiazole-Based Compounds Associated with Four Biological Activities.Molecules. 2021 Mar 7;26(5):1449. doi: 10.3390/molecules26051449. Molecules. 2021. PMID: 33800023 Free PMC article. Review.
-
2-Amino Thiazole Derivatives as Prospective Aurora Kinase Inhibitors against Breast Cancer: QSAR, ADMET Prediction, Molecular Docking, and Molecular Dynamic Simulation Studies.ACS Omega. 2023 Nov 7;8(46):44287-44311. doi: 10.1021/acsomega.3c07003. eCollection 2023 Nov 21. ACS Omega. 2023. PMID: 38027360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources